Devilee P - Search Results

1

[Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren].

Klijn JG, Devilee P, van Geel AN, Tilanus-Linthorst MM, Dudok-de Wit C, Meijers-Heijboer EJ. Klijn JG, et al. Among authors: devilee p. Ned Tijdschr Geneeskd. 1995 Mar 4;139(9):439-45. Ned Tijdschr Geneeskd. 1995. PMID: 7891765 Dutch.

2

[Cloning of the first gene for breast/ovarian cancer (BRCA1), mapping of a second gene locus (BRCA2) and consequences for clinical practice].

Oosterwijk JC, Devilee P, Meijers-Heijboer EJ, Menko FH, Klijn JG, Cornelisse CJ. Oosterwijk JC, et al. Among authors: devilee p. Ned Tijdschr Geneeskd. 1995 Mar 4;139(9):421-3. Ned Tijdschr Geneeskd. 1995. PMID: 7891762 Dutch. No abstract available.

3

Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer.

de Wit AC, Meijers-Heijboer EJ, Tibben A, Frets PG, Klijn JG, Devilee P, Niermeijer MF. de Wit AC, et al. Among authors: devilee p. Lancet. 1994 Jul 16;344(8916):197. Lancet. 1994. PMID: 7912795 No abstract available.

4

The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.

Peelen T, Cornelis RS, van Vliet M, Petrij-Bosch A, Cleton-Jansen AM, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, Devilee P. Peelen T, et al. Among authors: devilee p. Eur J Hum Genet. 1996;4(4):225-30. doi: 10.1159/000472203. Eur J Hum Genet. 1996. PMID: 8875189

5

BRCA1 in the family: a case description of the psychological implications.

DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Devilee P, Klijn JG, Oosterwijk JC, Niermeijer MF. DudokdeWit AC, et al. Among authors: devilee p. Am J Med Genet. 1997 Jul 11;71(1):63-71. doi: 10.1002/(sici)1096-8628(19970711)71:1<63::aid-ajmg12>3.0.co;2-t. Am J Med Genet. 1997. PMID: 9215771

6

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.

Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van 't Veer LJ, Bakker E, van Ommen GJ, Devilee P. Petrij-Bosch A, et al. Among authors: devilee p. Nat Genet. 1997 Nov;17(3):341-5. doi: 10.1038/ng1197-341. Nat Genet. 1997. PMID: 9354803 Free article.

7

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Wagner A, van den Ouweland A, Devilee P, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Among authors: devilee p. Lancet. 1998 Jan 31;351(9099):316-21. doi: 10.1016/s0140-6736(97)07065-7. Lancet. 1998. PMID: 9652611

8

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JG, Devilee P, Cornelisse CJ, Lasset C, Lenoir G, Barkardottir RB, Egilsson V, Hamann U, Chang-Claude J, Sobol H, Weber B, Stratton MR, Easton DF. Lakhani SR, et al. Among authors: devilee p. J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45. doi: 10.1093/jnci/90.15.1138. J Natl Cancer Inst. 1998. PMID: 9701363

9

Cancer risks in BRCA2 mutation carriers.

Breast Cancer Linkage Consortium. Breast Cancer Linkage Consortium. J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6. doi: 10.1093/jnci/91.15.1310. J Natl Cancer Inst. 1999. PMID: 10433620

10

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

Verhoog LC, Brekelmans CT, Seynaeve C, Dahmen G, van Geel AN, Bartels CC, Tilanus-Linthorst MM, Wagner A, Devilee P, Halley DJ, van den Ouweland AM, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Among authors: devilee p. J Clin Oncol. 1999 Nov;17(11):3396-402. doi: 10.1200/JCO.1999.17.11.3396. J Clin Oncol. 1999. PMID: 10550133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

430 results

Search Page